参考文献/References:
[1]Albers JW,Popbusui R.Diabetic neuropathy:mechanisms,emerging,Treatments,and subtypes[J].Curr Neurol Neurosci Rep,2014,14(18):473.
[2]Wang FP,Zhang PA,Yang XY.Updates on the Pathways of Toll-Like Receptors Mediated by HMGB1[J].J Mod Lab Med,2017,5,32(3):162-164.
[3]Ma YQ,Chen YR,Leng YF,et al.Tanshinone ⅡA Downregulates HMGB1 and TLR4 Expression in a Spinal Nerve Ligation Model of Neuropathic Pain[J].Evidence-Based Complementary and Alternative Medicine,2014(2014):639563.
[4]Nishida T,Tsubota M,Kawaishi Y,et al.Involvement of high mobility group box 1 in the development and maintenance of chemotherapy-induced peripheral neuropathy in rats[J].Toxicology,2016(365):48-58.
[5]Nam H,Kim HY,Choi JS,et al.Association between Serum 25-hydroxyvitamin D Levels and Type 2 Diabetes in Korean Adults[J].Chonnam Medical Journal,2017,53(1):73-77.
[6]Usluogullari CA,Balkan F,Caner S,et al.The relationship between microvascular complications and vitamin D deficiency in type 2 diabetes mellitus[J].BMC Endocrine Disorders,2015(15):33.
[7]Wieder-Huszla S,Jurczak A,Szkup M,et al.Relationships between Vitamin D3 and Metabolic Syndrome[J].Int J Environ Res Public Health,2019,16(2):175.
[8]文芳梅,严建宇.老年2型糖尿病患者血清25.羟维生素D3水平与胰岛素抵抗的相关性[J].中国医药导报,2016,13(24):77-80.
[9]张艳玲,张栩,张雯雯,等.济南地区成人血清25(OH)D水平与空腹血糖的相关性[J].山东大学学报(医学版),2014,52(3):59-63.
[10]Seham E,Abdelsadek,Entesar O,et al.Serum 25(OH)vitamin D level and itsrelation to diabetic peripheral neuropathyin Egyptian patients with type 2 diabetesmellitus[J].The Egyptian Journal of Neurology,Psychiatry and Neurosurgery,2018(54):36.
[11]Hosseini A,Abdollahi M.Diabetic neuropathy and oxidative stress:therapeutic perspectives[J].Oxidative Medicine and Cellular Longevity,2013(2013):168039.
[12]潘佳秋,徐微微,张超.新诊断2型糖尿病患者血清高迁移率族蛋白1和Toll样受体4水平变化及其与胰岛素抵抗的关系研究[J].中国全科医学,2013,16(3):252-254.
[13]陆海英,曲鹏,丁彦春等.2型糖尿病患者单核细胞TLR4表达及其与血浆TNF-α相关性研究[J].中国全科医学,2013, 16(3):252-254.
[14]Alam U,Arul-Devah V,Javed S,et al.Vitamin D and Diabetic Complications:True or FalseProphet[J].Diabetes Ther,2016,7(1):11-26.
[15]He R,Hu Y,Zeng H,et al.Vitamin D deficiency increases the risk of peripheral neuropathy in Chinese patients with type 2 diabetes[J].Diabetes Metab Res Rev,2017,33(2):e2820.
[16]Shillo P,Selvarajah D,Greig M,et al.Reduced vitamin D levels in painful diabetic peripheral neuropathy[J].Diabetic Medicine,2018,36(Suppl2):13789.
[17]李玉艳.维生素 D与2型糖尿病的相关性研究[J].医学信息,2016,29(32):277-278.
[18]赵新翠,陈婕.2型糖尿病患者周围神经病变患者转化生长因子13,与血清25-OH维生素D表达水平及相关性研究[J].检验医学与临床,2017,14(12):1802-1804.
[19]白秋芳,陈乐菊.糖尿病并发周围神经病变与血清25-羟维生素D3表达水平的相关性研究[J].现代医药卫生,2017,33(15):2257-2258.
[20]武红梅,黄莹,胡园园,等.血清MMP-9,25羟维生素D3表达与2型糖尿病周围神经病变相关性[J].辽宁医学院学报,2017,38(2):4-6.
[21]赵春楠,彭群新,李艳萌,等.基质金属蛋白酶组织抑制因子-1在2型糖尿病患者中的表达变化[J].广东医学,2014,35(6):888-890.
[22]Shehab D,Al-Jarallah K,Mojiminiyi OA,et al.Does vitamin D deficiency play a role in peripheral neuropathy in type 2 diabetes[J].Diabet Med,2012,29(1):43-49.
[23]Alamdari A,Mozafari R,Tafakhori A,et al.An inverse association between serum vitamin D levels with the presence and severity of impaired nerve conduction velocity and large fiber peripheral neuropathy in diabetic subjects[J].Neurol Sci,2015,36(7):1121-1126.
[24]Maser RE,Lenhard MJ,Pohlig RT.Vitamin D insufficiency is associated with reduced parasympathetic nerve fiber function in type 2 diabetes[J].Endocr Pract,2015,21(2):174-181.
[25]Lv WS,Zhao WJ,Gong SL,et al.Serum 25-hydroxyvitamin D levels and peripheral neuropathy in patients with type 2 diabetes:a systematic review and meta-analysis[J].J Endocrinol Invest,2015,38(5):513-518.
[26]Celikbilek A,Gocmen AY,Tanik N,et al.Decreased serum vitamin D levels are associated with diabetic peripheral neuropathy in a rural area of Turkey[J].Acta Neurol Belg,2015,115(1):47-52.
[27]Herrmann M,Sullivan DR,Veillard AS,et al.Serum 25-hydroxyvitamin D:a predictor of macrovascular and microvascular complications in patients with type 2 diabetes[J].Diabetes Care,2015,38(3):521-528.
[28]Qu GB,Wang LL,Tang X,et al.The association between vitamin D level and diabetic peripheral neuropathy in patients with type 2 diabetes mellitus:An update systematic review and meta-analysis[J].Journal of Clinical&Translational Endocrinology,2017,9(25):25-31.
[29]Cameron NE,Cotter MA.Effects of protein kinase cp inhibition on neurovascular dysfunction in diabetic rats:interackion with oxidative stress and essential fatty acid dysmetabolism[J].Diabetes Metah Res Rev,2002,18(4):315-323.
[30]Singh R,Barden A,Mo T,et al.Advanced glycation end-products:a review[J].Diabetologia,2001,44(2):129-146.
[31]Karachalias N,Babae-Jadidi R,Ahmed N,et al.Accumulation of fructosyl-lysine and advanced glycation end products in the kidney,retina and peripheral nerve of streptozotocin-induced diabetic rats[J].Biochemical Society Transactions,2003,31(6):1423-1425.
[32]Tongdao X,Qun D,Zhi W.Therapeutic effect of calcitriol on painful peripheral neuropathy in diabetic patients[J].Cli Res,2016,24(12):60-61.
[33]Bener A,Al-Hamaq AO,Kurtulus EM,et al.The role of vitamin D, obesity and physical exercise in regulation of glycemia in Type 2 Diabetes Mellitus patients[J].Diabetes&metabolic syndrome,2016,10(4):198-204.
[34]秦宏超,张真稳.2型糖尿病周围神经病变患者外周血CD4+调节性T细胞与25-(OH)D3的关系及其意义[J].中国现代医学杂志,2018,28(18):45-49.
[35]Fan L,Zhang Y,Zhu J,et al.Association of vitamin D deficiency with diabetic peripheral neuropathy and diabetic nephropathy in Tianjin, China[J].Asia Pac J Clin Nutr,2018,27(3):599-606.
[36]Qu GB,Wang LL,Tang X,et al.The association between vitamin D level and diabetic peripheral neuropathy in patients with type 2 diabetes mellitus: An update systematic review and meta-analysis[J].J Clin Transl Endocrinol,2017,9(9):25-31.
[37]Bilir B,Tulubas F,Bilir BE,et al.The association of vitamin D with inflammatory cytokines in diabetic peripheral neuropathy[J].Journal of Physical Therapy Science,2016,28(7):2159-2163.
[38]Hehab D,Al-Jarallah K,Mojiminiyi OA,et al.Does Vitamin D deficiency play a role in peripheral neuropathy in Type 2 diabetes?[J].Diabetic Medicine,2014,29(1):43-49.
[39]Lv WS,Zhao WJ,Gong SL,et al.Serum 25-hydroxyvitamin D levels and peripheral neuropathy in patients with type 2 diabetes[J].J Endocrinol Invest,2015,38(5):513-518.
[40]尹秀梅,游娜,缪珩,等.补充维生素D对肥胖或糖代谢异常患者胰岛素抵抗及血糖改善效果的Meta分析[J].中华内分泌代谢杂志,2016,32(8):663-667.
[41]Yan ZT,Liu YS.Relationship between blood lipids,blood glucose,inflammatory factors and type 2 diabetes mellitus and its complications[J].Int J Lab Med,2018,39(18):2296-2299.